Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IONCLAD
- Development stage
- Preclinical
- Lead developer
- Iasis Molecular Sciences
- Modality
- Nanoparticles → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems, Implantable Devices → Device-based Delivery → Drug Delivery Systems
- Administration
- Topical
01
Overview
IONCLAD is an antimicrobial materials platform developed by Iasis Molecular Sciences, designed to combat healthcare-associated infections (HAIs) by preventing microbial colonization on medical devices and clinical surfaces. The technology utilizes advanced materials and polymer fillers infused with antimicrobial metal ions, primarily silver and copper. These ions are released or act upon contact to destroy or inhibit the growth of a broad spectrum of pathogens, including bacteria, viruses (such as SARS-CoV-2 and influenza), and fungi. IONCLAD is integrated into various medical applications, most notably the SOTERION Foley catheter, and can be applied as a coating to wound dressings, endotracheal tubes, and architectural surfaces in healthcare settings. Unlike systemic antibiotics, IONCLAD provides localized, surface-level protection to prevent the formation of biofilms and the transmission of infections.
- Brand names
- IONCLAD
- Other names
- IONCLAD antimicrobial materialsIONCLAD ANTIMICROBIALS
Beyond the preview
Go deeper on IONCLAD.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IONCLAD.